30 results
424B5
NDRA
ENDRA Life Sciences Inc
28 Apr 23
Prospectus supplement for primary offering
4:51pm
to stock analysts, stock brokers, institutional investors, and others in the investor community. In addition, investors may be risk averse to investments
PRE 14A
0qlh3nxxe svojal
17 Apr 20
Preliminary proxy
4:18pm
8-K
0bdu5qr1opt0489sgx
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
424B3
pjf4ltkqkd
28 Jan 20
Prospectus supplement
4:59pm